U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX1354279: GSM1911094: BMDC footprints, lactimidomycin-treated, LPS stimulated; Mus musculus; OTHER
1 ILLUMINA (Illumina HiSeq 2500) run: 369.2M spots, 18.8G bases, 11.5Gb downloads

Submitted by: NCBI (GEO)
Study: A regression-based analysis of ribosome-profiling data reveals a conserved complexity to mammalian translation
show Abstracthide Abstract
A fundamental goal of genomics is to identify the complete set of expressed proteins. Automated annotation strategies rely on assumptions about protein-coding sequences (CDSs), e.g., they are conserved, do not overlap, and exceed a minimum length. However, an increasing number of newly discovered proteins violate these rules. Here we present an experimental and analytical framework, based on ribosome profiling and linear regression, for systematic identification and quantification of translation. Application of this approach to lipopolysaccharide-stimulated mouse dendritic cells and HCMV-infected human fibroblasts identifies thousands of novel CDSs, including micropeptides and variants of known proteins, that bear the hallmarks of canonical translation and exhibit comparable translation levels and dynamics to annotated CDSs. Remarkably, many translation events are identified in both mouse and human cells even when the peptide sequence is not conserved. Our work thus reveals an unexpected complexity to mammalian translation suited to provide both conserved regulatory or protein-based functions. Overall design: 37 ribosome footprint samples from mouse BMDCs across a time course of LPS stimulation and in the presence or absence of translation inhibitors cycloheximide, harringtonine, or lactimidomycin. A mock (non-LPS stimulated) time course is also included, collected in the presence of cycloheximide. Two replicates are available for the LPS timecourse under CHX treatment. Reads include the 3'' linker sequence CTGTAGGCACCATCAAT.
Sample: BMDC footprints, lactimidomycin-treated, LPS stimulated
SAMN04194189 • SRS1120861 • All experiments • All runs
Organism: Mus musculus
Library:
Instrument: Illumina HiSeq 2500
Strategy: OTHER
Source: TRANSCRIPTOMIC
Selection: other
Layout: SINGLE
Construction protocol: Following treatment with indicated ribosome inhibitors, cells were lysed by triturating 10 times with 400 μL lysis buffer (20 mM Tris pH 7.56, 150 mM NaCl, 5 mM MgCl2, 1% Triton X-100 [Sigma], 1 mM DTT [Sigma], 8% glycerol, 100 μg/mL CHX, 12 units/mL Turbo DNase [Life Technologies]). Lysates were clarified by centrifuging at 20,000×g for 10 min at 4°C. Clarified lysate was flash frozen in liquid nitrogen. Clarified cell lysates were treated with RNase I (Life Technologies) to digest RNA not protected by ribosomes. High molecular weight species were isolated by centrifuging lysates through a 34% sucrose cushion at 200,000×g for 4 hours at 4°C. Pellets were resuspended in Trizol (Life Technologies) and the RNA fraction isolated. Contaminant rRNA was removed using the listed strategies. Total RNase I-treated RNA was size-separated by gel electrophoresis, and RNAs of size 28–34 nucleotides were purified. These ribosome protected fragments were cloned and sequenced via a single-end run on an Illumina HiSeq 2500 sequencer.
Experiment attributes:
GEO Accession: GSM1911094
Links:
Runs: 1 run, 369.2M spots, 18.8G bases, 11.5Gb
Run# of Spots# of BasesSizePublished
SRR2724709369,186,40018.8G11.5Gb2015-12-04

ID:
1931889

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...